<DOC>
	<DOCNO>NCT00280280</DOCNO>
	<brief_summary>The purpose pilot study evaluate safety efficacy Botox® compare safety efficacy oral baclofen reduce muscle tone-related disability result neurological damage stable neurological disorder evaluate drug-therapy tolerance .</brief_summary>
	<brief_title>Botox vs. Baclofen Upper Limb Spasticity</brief_title>
	<detailed_description>Spasticity result injury central nervous system , include brain spinal cord . Illnesses injury typically cause spasticity include cerebral palsy , stroke , multiple sclerosis traumatic brain spinal cord injury . Common treatment spasticity include physical occupational therapy well oral medication baclofen , injected medication botulinum neurotoxin , intrathecal medication surgical procedure . The approach treatment spasticity comprehensive nature therapy widely apply broad population patient include child , adult old adult . This single-center , randomize , prospective , parallel , double-blind study . Study duration approximately 16 weeks.At Visit 2 ( Baseline Visit ) , eligible study subject randomize one two treatment group : intramuscular Botox plus oral placebo , intramuscular placebo plus oral baclofen .</detailed_description>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Outpatient , male female subject race , least 18 year age . Female subject childbearing potential must negative urine pregnancy test result Baseline ( test must sensitivity least 50mlU/ml human chorionic gonadotropin ) practice reliable method contraception throughout study ; Minimal 4month history stable neurological disorder result focal upper limb muscle spasticity ( wrist and/or elbow ) Disability Assessment Scale ( DAS ) ≥ 2 principal therapeutic intervention target choose Investigator Subject ( i.e. , hygiene , dress , pain cosmesis ) . Subjects able understand requirement study sign Informed Consent/HIPAA Authorization form . Female subject pregnant ( positive urine pregnancy test ) infant breastfeed childbearing potential practicing reliable method birth control . Severe contracture wrist history tendon transfer study limb . Cast study limb within four week Visit 1 . Profound atrophy muscle target area ( ) injection . Progressive neurological disorder ( e.g. , multiple sclerosis ) . Myasthenia Gravis , EatonLambert Syndrome , Amyotrophic Lateral Sclerosis disease might interfere neuromuscular function . Orthostatic hypotension current use alpha2 adrenergic agonist ( e.g . clonidine ) . Current anticoagulant therapy INR &gt; 3.5 Significantly impaired renal and/or hepatic function , opinion Investigator . Failure meet prohibit concomitant medication criterion ( Supplement I ) Subjects plan inpatient surgery study . Any uncontrolled systemic disease . Allergy sensitivity component study medication . Recent alcohol drug abuse . History poor cooperation , noncompliance medical treatment , unreliability . Subjects currently participate investigational drug study participate investigational drug study within 30 day Baseline Visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>spasticity</keyword>
	<keyword>Botox</keyword>
	<keyword>baclofen</keyword>
</DOC>